{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioinformatics", "nanomedicine", "nanoparticles", "neurodegenerative diseases", "phytomedicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35160749", "DateRevised": {"Year": "2022", "Month": "02", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "21"}], "Language": ["eng"], "ELocationID": ["804", "10.3390/ma15030804"], "Journal": {"ISSN": "1996-1944", "JournalIssue": {"Volume": "15", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "21"}}, "Title": "Materials (Basel, Switzerland)", "ISOAbbreviation": "Materials (Basel)"}, "ArticleTitle": "Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders.", "Abstract": {"AbstractText": ["The strategies involved in the development of therapeutics for neurodegenerative disorders are very complex and challenging due to the existence of the blood-brain barrier (BBB), a closely spaced network of blood vessels and endothelial cells that functions to prevent the entry of unwanted substances in the brain. The emergence and advancement of nanotechnology shows favourable prospects to overcome this phenomenon. Engineered nanoparticles conjugated with drug moieties and imaging agents that have dimensions between 1 and 100 nm could potentially be used to ensure enhanced efficacy, cellular uptake, specific transport, and delivery of specific molecules to the brain, owing to their modified physico-chemical features. The conjugates of nanoparticles and medicinal plants, or their components known as nano phytomedicine, have been gaining significance lately in the development of novel neuro-therapeutics owing to their natural abundance, promising targeted delivery to the brain, and lesser potential to show adverse effects. In the present review, the promising application, and recent trends of combined nanotechnology and phytomedicine for the treatment of neurological disorders (ND) as compared to conventional therapies, have been addressed. Nanotechnology-based efforts performed in bioinformatics for early diagnosis as well as futuristic precision medicine in ND have also been discussed in the context of computational approach."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Innovation, Incubation & Industry (i-cube) Laboratory, Techno India NJR Institute of Technology, Udaipur 313003, India."}, {"Identifier": [], "Affiliation": "Department of Science & Engineering, Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia."}], "LastName": "Bhattacharya", "ForeName": "Tanima", "Initials": "T"}, {"Identifier": ["0000-0002-6738-2459"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Biological Chemistry, University of Toledo, 3000 Arlington Ave., Toledo, OH 43614, USA."}], "LastName": "Soares", "ForeName": "Giselle Amanda Borges E", "Initials": "GABE"}, {"Identifier": ["0000-0001-8867-7603"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India."}], "LastName": "Chopra", "ForeName": "Hitesh", "Initials": "H"}, {"Identifier": ["0000-0003-2357-283X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh."}], "LastName": "Rahman", "ForeName": "Md Mominur", "Initials": "MM"}, {"Identifier": ["0000-0003-3679-8766"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences & Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Hasan", "ForeName": "Ziaul", "Initials": "Z"}, {"Identifier": ["0000-0001-5089-8304"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Microbiology and NCDs, ICMR-Regional Medical Research Center, Chandrasekharpur, Bhubaneshwar 751023, India."}], "LastName": "Swain", "ForeName": "Shasank S", "Initials": "SS"}, {"Identifier": ["0000-0001-7810-8925"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania."}], "LastName": "Cavalu", "ForeName": "Simona", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Materials (Basel)", "NlmUniqueID": "101555929", "ISSNLinking": "1996-1944"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bensadoun J.-C., Almeida L.P.d., Fine E.G., Tseng J.L., D\u00e9glon N., Aebischer P. Comparative study of GDNF delivery systems for the CNS: Polymer rods, encapsulated cells, and lentiviral vectors. J. Control. Release. 2003;87:107\u2013115. doi: 10.1016/S0168-3659(02)00353-X.", "ArticleIdList": ["10.1016/S0168-3659(02)00353-X", "12618027"]}, {"Citation": "Kishima H., Poyot T., Bloch J., Dauguet J., Conde F., Dolle F., Hinnen F., Pralong W., Palfi S., Deglon N., et al. Encapsulated GDNF-producing C2C12 cells for Parkinson\u2019s disease: A pre-clinical study in chronic MPTP-treated baboons. Neurobiol. Dis. 2004;16:428\u2013439. doi: 10.1016/j.nbd.2004.03.012.", "ArticleIdList": ["10.1016/j.nbd.2004.03.012", "15193299"]}, {"Citation": "McArthur J.C. HIV dementia: An evolving disease. J. Neuroimmunol. 2004;157:3\u201310. doi: 10.1016/j.jneuroim.2004.08.042.", "ArticleIdList": ["10.1016/j.jneuroim.2004.08.042", "15579274"]}, {"Citation": "Menei P., Montero-Menei C., Venier M.C., Benoit J.P. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin. Drug Deliv. 2005;2:363\u2013376. doi: 10.1517/17425247.2.2.363.", "ArticleIdList": ["10.1517/17425247.2.2.363", "16296760"]}, {"Citation": "Flachenecker P. Epidemiology of neuroimmunological diseases. J. Neurol. 2006;253((Suppl. 5)):V2\u2013V8. doi: 10.1007/s00415-006-5001-3.", "ArticleIdList": ["10.1007/s00415-006-5001-3", "16998750"]}, {"Citation": "Kabanov A.V., Gendelman H.E. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 2007;32:1054\u20131082. doi: 10.1016/j.progpolymsci.2007.05.014.", "ArticleIdList": ["10.1016/j.progpolymsci.2007.05.014", "PMC2838200", "20234846"]}, {"Citation": "Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., et al. Global prevalence of dementia: A Delphi consensus study. Lancet. 2005;366:2112\u20132117. doi: 10.1016/S0140-6736(05)67889-0.", "ArticleIdList": ["10.1016/S0140-6736(05)67889-0", "PMC2850264", "16360788"]}, {"Citation": "Popovic N., Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int. J. Pharm. 2006;314:120\u2013126. doi: 10.1016/j.ijpharm.2005.09.040.", "ArticleIdList": ["10.1016/j.ijpharm.2005.09.040", "16529886"]}, {"Citation": "Singh N., Pillay V., Choonara Y.E. Advances in the treatment of Parkinson\u2019s disease. Prog. Neurobiol. 2007;81:29\u201344. doi: 10.1016/j.pneurobio.2006.11.009.", "ArticleIdList": ["10.1016/j.pneurobio.2006.11.009", "17258379"]}, {"Citation": "Tysnes O.B., Storstein A. Epidemiology of Parkinson\u2019s disease. J. Neura. Transm. (Vienna) 2017;124:901\u2013905. doi: 10.1007/s00702-017-1686-y.", "ArticleIdList": ["10.1007/s00702-017-1686-y", "28150045"]}, {"Citation": "Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., et al. Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N. Engl. J. Med. 2001;344:710\u2013719. doi: 10.1056/NEJM200103083441002.", "ArticleIdList": ["10.1056/NEJM200103083441002", "11236774"]}, {"Citation": "Pollak P., Fraix V., Krack P., Moro E., Mendes A., Chabardes S., Koudsie A., Benabid A.-L. Treatment results: Parkinson\u2019s disease. Mov. Disord. 2002;17:S75\u2013S83. doi: 10.1002/mds.10146.", "ArticleIdList": ["10.1002/mds.10146", "11948759"]}, {"Citation": "Johnson W.G. Late-onset neurodegenerative diseases\u2014The role of protein insolubility. Pt 4J. Anat. 2000;196:609\u2013616. doi: 10.1046/j.1469-7580.2000.19640609.x.", "ArticleIdList": ["10.1046/j.1469-7580.2000.19640609.x", "PMC1468101", "10923991"]}, {"Citation": "Dickson D.W. Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease. J. Clin. Investig. 2002;110:1403\u20131405. doi: 10.1172/JCI0217164.", "ArticleIdList": ["10.1172/JCI0217164", "PMC151824", "12438436"]}, {"Citation": "Woodruff B.K., Graff-Radford N.R., Ferman T.J., Dickson D.W., DeLucia M.W., Crook J.E., Arvanitakis Z., Brassler S., Waters C., Barker W., et al. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006;66:1949\u20131950. doi: 10.1212/01.wnl.0000219812.20616.b3.", "ArticleIdList": ["10.1212/01.wnl.0000219812.20616.b3", "16801670"]}, {"Citation": "Walia V., Kaushik D., Mittal V., Kumar K., Verma R., Parashar J., Akter R., Rahman M.H., Bhatia S., Al-Harrasi A., et al. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer\u2019s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside. Mol. Neurobiol. 2021 doi: 10.1007/s12035-021-02617-1.", "ArticleIdList": ["10.1007/s12035-021-02617-1", "34751889"]}, {"Citation": "Nischwitz V., Berthele A., Michalke B. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal. Chim. Act. 2008;627:258\u2013269. doi: 10.1016/j.aca.2008.08.018.", "ArticleIdList": ["10.1016/j.aca.2008.08.018", "18809082"]}, {"Citation": "Gendelman H.E., Ding S., Gong N., Liu J., Ramirez S.H., Persidsky Y., Mosley R.L., Wang T., Volsky D.J., Xiong H. Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration. J. Neuroimmune Pharm. 2009;4:47\u201359. doi: 10.1007/s11481-008-9135-1.", "ArticleIdList": ["10.1007/s11481-008-9135-1", "PMC2657224", "19034671"]}, {"Citation": "Modi G., Pillay V., Choonara Y.E., Ndesendo V.M., du Toit L.C., Naidoo D. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog. Neurobiol. 2009;88:272\u2013285. doi: 10.1016/j.pneurobio.2009.05.002.", "ArticleIdList": ["10.1016/j.pneurobio.2009.05.002", "19486920"]}, {"Citation": "Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Moher D. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J. Clin. Epidemiol. 2021;134:103\u2013112. doi: 10.1016/j.jclinepi.2021.02.003.", "ArticleIdList": ["10.1016/j.jclinepi.2021.02.003", "33577987"]}, {"Citation": "Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J. Clin. Epidemiol. 2021;134:178\u2013189. doi: 10.1016/j.jclinepi.2021.03.001.", "ArticleIdList": ["10.1016/j.jclinepi.2021.03.001", "33789819"]}, {"Citation": "Kim J., Mook-Jung I. Special issue on neurodegenerative diseases and their therapeutic approaches. Exp. Mol. Med. 2015;47:e146. doi: 10.1038/emm.2015.13.", "ArticleIdList": ["10.1038/emm.2015.13", "PMC4351416", "25766615"]}, {"Citation": "Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 2004;16:1\u201313. doi: 10.1016/j.nbd.2003.12.016.", "ArticleIdList": ["10.1016/j.nbd.2003.12.016", "15207256"]}, {"Citation": "Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010;37:13\u201325. doi: 10.1016/j.nbd.2009.07.030.", "ArticleIdList": ["10.1016/j.nbd.2009.07.030", "19664713"]}, {"Citation": "Silva G.A. Neuroscience nanotechnology: Progress, opportunities and challenges. Nat. Rev. Neurosci. 2006;7:65\u201374. doi: 10.1038/nrn1827.", "ArticleIdList": ["10.1038/nrn1827", "16371951"]}, {"Citation": "Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: Current status and future prospects. FASEB J. 2005;19:311\u2013330. doi: 10.1096/fj.04-2747rev.", "ArticleIdList": ["10.1096/fj.04-2747rev", "15746175"]}, {"Citation": "Goldsmith M., Abramovitz L., Peer D. Precision nanomedicine in neurodegenerative diseases. ACS Nano. 2014;8:1958\u20131965. doi: 10.1021/nn501292z.", "ArticleIdList": ["10.1021/nn501292z", "24660817"]}, {"Citation": "Illum L. Nasal drug delivery\u2014Possibilities, problems and solutions. J. Control. Release. 2003;87:187\u2013198. doi: 10.1016/S0168-3659(02)00363-2.", "ArticleIdList": ["10.1016/S0168-3659(02)00363-2", "12618035"]}, {"Citation": "Pardridge W.M. CSF, blood-brain barrier, and brain drug delivery. Expert Opin. Drug Deliv. 2016;13:963\u2013975. doi: 10.1517/17425247.2016.1171315.", "ArticleIdList": ["10.1517/17425247.2016.1171315", "27020469"]}, {"Citation": "McDannold N., Arvanitis C.D., Vykhodtseva N., Livingstone M.S. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: Safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012;72:3652\u20133663. doi: 10.1158/0008-5472.CAN-12-0128.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-0128", "PMC3533365", "22552291"]}, {"Citation": "Dasgupta A., Liu M., Ojha T., Storm G., Kiessling F., Lammers T. Ultrasound-mediated drug delivery to the brain: Principles, progress and prospects. Drug Discov. Today Technol. 2016;20:41\u201348. doi: 10.1016/j.ddtec.2016.07.007.", "ArticleIdList": ["10.1016/j.ddtec.2016.07.007", "PMC5166975", "27986222"]}, {"Citation": "Cheng Z., Zhang J., Liu H., Li Y., Zhao Y., Yang E. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer\u2019s disease-related animal models despite reported blood-brain barrier disruption. Drug Metab. Dispos. 2010;38:1355\u20131361. doi: 10.1124/dmd.110.033324.", "ArticleIdList": ["10.1124/dmd.110.033324", "20427691"]}, {"Citation": "Roy Chowdhury S., Mondal S., Muthuraj B., Balaji S.N., Trivedi V., Krishnan Iyer P. Remarkably Efficient Blood-Brain Barrier Crossing Polyfluorene-Chitosan Nanoparticle Selectively Tweaks Amyloid Oligomer in Cerebrospinal Fluid and Abeta1-40. ACS Omega. 2018;3:8059\u20138066. doi: 10.1021/acsomega.8b00764.", "ArticleIdList": ["10.1021/acsomega.8b00764", "PMC6072248", "30087934"]}, {"Citation": "Cavalu S., Damian G. Rotational Correlation Times of 3-Carbamoyl-2,2,5,5-Tetramethyl-3-Pyrrolin-1-Yloxy Spin Label with Respect to Heme and Nonheme Proteins. Biomacromolecules. 2003;4:1630\u20131635. doi: 10.1021/bm034093z.", "ArticleIdList": ["10.1021/bm034093z", "14606889"]}, {"Citation": "Kaushik A.C., Kumar A., Peng Z., Khan A., Junaid M., Ali A., Bharadwaj S., Wei D.-Q. Evaluation and validation of synergistic effects of amyloid-beta inhibitor\u2013gold nanoparticles complex on Alzheimer\u2019s disease using deep neural network approach. J. Mater. Res. 2019;34:1845\u20131853. doi: 10.1557/jmr.2018.452.", "ArticleIdList": ["10.1557/jmr.2018.452"]}, {"Citation": "Choi C.H., Alabi C.A., Webster P., Davis M.E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl. Acad. Sci. USA. 2010;107:1235\u20131240. doi: 10.1073/pnas.0914140107.", "ArticleIdList": ["10.1073/pnas.0914140107", "PMC2824286", "20080552"]}, {"Citation": "Kong S.D., Lee J., Ramachandran S., Eliceiri B.P., Shubayev V.I., Lal R., Jin S. Magnetic targeting of nanoparticles across the intact blood-brain barrier. J. Control. Release. 2012;164:49\u201357. doi: 10.1016/j.jconrel.2012.09.021.", "ArticleIdList": ["10.1016/j.jconrel.2012.09.021", "PMC4440873", "23063548"]}, {"Citation": "Smith M.W., Gumbleton M. Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies. J. Drug Target. 2006;14:191\u2013214. doi: 10.1080/10611860600650086.", "ArticleIdList": ["10.1080/10611860600650086", "16777679"]}, {"Citation": "Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989;55:R1\u2013R4. doi: 10.1016/0378-5173(89)90281-0.", "ArticleIdList": ["10.1016/0378-5173(89)90281-0"]}, {"Citation": "Mora-Huertas C.E., Fessi H., Elaissari A. Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods critical comparison. Adv. Colloid. Interface Sci. 2011;163:90\u2013122. doi: 10.1016/j.cis.2011.02.005.", "ArticleIdList": ["10.1016/j.cis.2011.02.005", "21376297"]}, {"Citation": "Cavalu S., Bisboaca S., Mates I.M., Pasca P.M., Laslo V., Costea T., Fritea L., Vicas S. Novel Formulation Based on Chitosan-Arabic Gum Nanoparticles Entrapping Propolis Extract Production, physico-chemical and structural characterization. Rev. Chim. 2018;69:3756\u20133760. doi: 10.37358/RC.18.12.6836.", "ArticleIdList": ["10.37358/RC.18.12.6836"]}, {"Citation": "Erdogar N., Akkin S., Bilensoy E. Nanocapsules for Drug Delivery: An Updated Review of the Last Decade. Recent Pat. Drug Deliv. Formul. 2018;12:252\u2013266. doi: 10.2174/1872211313666190123153711.", "ArticleIdList": ["10.2174/1872211313666190123153711", "30674269"]}, {"Citation": "Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J. Control. Release. 1993;25:89\u201398. doi: 10.1016/0168-3659(93)90097-O.", "ArticleIdList": ["10.1016/0168-3659(93)90097-O"]}, {"Citation": "Murakami H., Kobayashi M., Takeuchi H., Kawashima Y. Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm. 1999;187:143\u2013152. doi: 10.1016/S0378-5173(99)00187-8.", "ArticleIdList": ["10.1016/S0378-5173(99)00187-8", "10502620"]}, {"Citation": "Quintanar-Guerrero D., Allemann E., Fessi H., Doelker E. Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation. Int. J. Pharm. 1999;188:155\u2013164. doi: 10.1016/S0378-5173(99)00216-1.", "ArticleIdList": ["10.1016/S0378-5173(99)00216-1", "10518671"]}, {"Citation": "Yusuf M., Khan M., Khan R.A., Ahmed B. Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J. Drug Target. 2013;21:300\u2013311. doi: 10.3109/1061186X.2012.747529.", "ArticleIdList": ["10.3109/1061186X.2012.747529", "23231324"]}, {"Citation": "McCall R.L., Sirianni R.W. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J. Vis. Exp. 2013;82:51015. doi: 10.3791/51015.", "ArticleIdList": ["10.3791/51015", "PMC4106449", "24429733"]}, {"Citation": "Huang W., Zhang C. Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation. Biotechnol. J. 2018;13:1700203. doi: 10.1002/biot.201700203.", "ArticleIdList": ["10.1002/biot.201700203", "PMC5924600", "28941234"]}, {"Citation": "Cavalu S., Prokisch J., Laslo V., Vicas S. Preparation, structural characterisation and release study of novel hybrid microspheres entrapping nanoselenium, produced by green synthesis. IET Nanobiotechnol. 2017;11:426\u2013432. doi: 10.1049/iet-nbt.2016.0107.", "ArticleIdList": ["10.1049/iet-nbt.2016.0107", "PMC8675991", "28530192"]}, {"Citation": "Tarhini M., Greige-Gerges H., Elaissari A. Protein-based nanoparticles: From preparation to encapsulation of active molecules. Int. J. Pharm. 2017;522:172\u2013197. doi: 10.1016/j.ijpharm.2017.01.067.", "ArticleIdList": ["10.1016/j.ijpharm.2017.01.067", "28188876"]}, {"Citation": "Zhang D., Ma X.L., Gu Y., Huang H., Zhang G.W. Green Synthesis of Metallic Nanoparticles and Their Potential Applications to Treat Cancer. Front. Chem. 2020;8:799. doi: 10.3389/fchem.2020.00799.", "ArticleIdList": ["10.3389/fchem.2020.00799", "PMC7658653", "33195027"]}, {"Citation": "Cavalu S., Antoniac I.V., Mohan A., Bodog F., Doicin C., Mates I., Ulmeanu M., Murzac R., Semenescu A. Nanoparticles and Nanostructured Surface Fabrication for Innovative Cranial and Maxillofacial Surgery. Materials. 2020;13:5391. doi: 10.3390/ma13235391.", "ArticleIdList": ["10.3390/ma13235391", "PMC7731022", "33260938"]}, {"Citation": "Velmurugan B.K., Rathinasamy B., Lohanathan B.P., Thiyagarajan V., Weng C.F. Neuroprotective Role of Phytochemicals. Molecules. 2018;23:2485. doi: 10.3390/molecules23102485.", "ArticleIdList": ["10.3390/molecules23102485", "PMC6222499", "30262792"]}, {"Citation": "Xu J., Wold E.A., Ding Y., Shen Q., Zhou J. Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection. Molecules. 2018;23:474. doi: 10.3390/molecules23020474.", "ArticleIdList": ["10.3390/molecules23020474", "PMC6017549", "29470395"]}, {"Citation": "Hajialyani M., Hosein Farzaei M., Echeverria J., Nabavi S.M., Uriarte E., Sobarzo-Sanchez E. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence. Molecules. 2019;24:648. doi: 10.3390/molecules24030648.", "ArticleIdList": ["10.3390/molecules24030648", "PMC6384806", "30759833"]}, {"Citation": "Tripathy N., Ahmad R., Khang G. Inorganic Nanotheranostics: Strategy development and applications. Drug Deliv. Nanosyst. Biomed. Appl. 2018:377\u2013419. doi: 10.1016/B978-0-323-50922-0.00017-1.", "ArticleIdList": ["10.1016/B978-0-323-50922-0.00017-1"]}, {"Citation": "Bar-Zeev M., Livney Y.D., Assaraf Y.G. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. Drug Resist. Updat. 2017;31:15\u201330. doi: 10.1016/j.drup.2017.05.002.", "ArticleIdList": ["10.1016/j.drup.2017.05.002", "28867241"]}, {"Citation": "Lausanne E.P.F.D. On the Way to Nanotheranostics: Diagnosing and Treating Diseases Simultaneously.  [(accessed on 15 May 2021)].  Available online:  www.sciencedaily.com/releases/2019/07/190708131203.htm."}, {"Citation": "Bandelow B., Michaelis S., Wedekind D. Treatment of anxiety disorders. Dialogues. Clin. Neurosci. 2017;19:93\u2013107.", "ArticleIdList": ["PMC5573566", "28867934"]}, {"Citation": "Powell C.R., Dillon K.M., Matson J.B. A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications. Biochem. Pharmacol. 2018;149:110\u2013123. doi: 10.1016/j.bcp.2017.11.014.", "ArticleIdList": ["10.1016/j.bcp.2017.11.014", "PMC5866188", "29175421"]}, {"Citation": "Shang A., Cao S.Y., Xu X.Y., Gan R.Y., Tang G.Y., Corke H., Mavumengwana V., Li H.B. Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.) Foods. 2019;8:246. doi: 10.3390/foods8070246.", "ArticleIdList": ["10.3390/foods8070246", "PMC6678835", "31284512"]}, {"Citation": "Chen X., Pan W. The treatment strategies for neurodegenerative diseases by integrative medicine. Integr. Med. Int. 2014;1:223\u2013225. doi: 10.1159/000381546.", "ArticleIdList": ["10.1159/000381546"]}, {"Citation": "Roy S., Awasthi H. Herbal medicines as neuroprotective agent: A mechanistic approach. Int. J. Pharm. Pharm. Sci. 2017;9:1\u20137. doi: 10.22159/ijpps.2017v9i11.19444.", "ArticleIdList": ["10.22159/ijpps.2017v9i11.19444"]}, {"Citation": "Chopra H., Dey P.S., Das D., Bhattacharya T., Shah M., Mubin S., Maishu S.P., Akter R., Rahman M.H., Karthika C., et al. Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets. Molecules. 2021;26:4998. doi: 10.3390/molecules26164998.", "ArticleIdList": ["10.3390/molecules26164998", "PMC8402133", "34443593"]}, {"Citation": "Soares G.A.B.e., Bhattacharya T., Chakrabarti T., Tagde P., Cavalu S. Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System. Plants. 2021;11:21. doi: 10.3390/plants11010021.", "ArticleIdList": ["10.3390/plants11010021", "PMC8747111", "35009027"]}, {"Citation": "Jakka A. A Study on Nootropic Activity of Celastrus Paniculata Willd Whole Plant Methanolic Extract in Rats. Asian J. Pharm. Clin. Res. 2016;9:336\u2013341."}, {"Citation": "Amadi C.N., Offor S.J., Frazzoli C., Orisakwe O.E. Natural antidotes and management of metal toxicity. Environ. Sci. Pollut. Res. Int. 2019;26:18032\u201318052. doi: 10.1007/s11356-019-05104-2.", "ArticleIdList": ["10.1007/s11356-019-05104-2", "31079302"]}, {"Citation": "Ashraf A., Zafar S., Zahid K., Salahuddin Shah M., Al-Ghanim K.A., Al-Misned F., Mahboob S. Synthesis, characterization, and antibacterial potential of silver nanoparticles synthesized from Coriandrum sativum L. J. Infect. Public Health. 2019;12:275\u2013281. doi: 10.1016/j.jiph.2018.11.002.", "ArticleIdList": ["10.1016/j.jiph.2018.11.002", "30477919"]}, {"Citation": "Owoeye O., Obazie F.I., Atiba F.A., Malomo A.O. Comparative Neuroprotective Effect of Celosia argentea Linn. and Vitamin E on Mercury-induced Oxidative and Histological Parameters of Rat Brain. Niger. J. Physiol. Sci. 2019;34:167\u2013175.", "ArticleIdList": ["32343268"]}, {"Citation": "Yang S., Chang M.C. Chronic Pain: Structural and Functional Changes in Brain Structures and Associated Negative Affective States. Int. J. Mol. Sci. 2019;20:3130. doi: 10.3390/ijms20133130.", "ArticleIdList": ["10.3390/ijms20133130", "PMC6650904", "31248061"]}, {"Citation": "Yuan Q., Wang C.W., Shi J., Lin Z.X. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. J. Ethnopharmacol. 2017;195:1\u20139. doi: 10.1016/j.jep.2016.12.005.", "ArticleIdList": ["10.1016/j.jep.2016.12.005", "27940086"]}, {"Citation": "Abdolmaleki A., Akram M., Saeed M.M., Asadi A., Kajkolah M. Herbal medicine as neuroprotective potential agent in human and animal models: A historical overview. J. Pharm. Care. 2020;8:75\u201382. doi: 10.18502/jpc.v8i2.3832.", "ArticleIdList": ["10.18502/jpc.v8i2.3832"]}, {"Citation": "Bridi H., Meirelles G.C., von Poser G.L. Structural diversity and biological activities of phloroglucinol derivatives from Hypericum species. Phytochemistry. 2018;155:203\u2013232. doi: 10.1016/j.phytochem.2018.08.002.", "ArticleIdList": ["10.1016/j.phytochem.2018.08.002", "30153613"]}, {"Citation": "Agatonovic-Kustrin S., Kettle C., Morton D.W. A molecular approach in drug development for Alzheimer\u2019s disease. Biomed. Pharm. 2018;106:553\u2013565. doi: 10.1016/j.biopha.2018.06.147.", "ArticleIdList": ["10.1016/j.biopha.2018.06.147", "29990843"]}, {"Citation": "Eudes J.F., Silveria D., Soares A.C., Carneiro F.P., de Assis M.S., Leite F.B., Niraldo P., Greice M.S., M\u00f4nica V.d.S., St\u00e9phanie M., et al. Effects of lemon balm (Melissa officinalis) on behavioral deficits and memory impairment of rats surviving sepsis. J. Med. Plants Res. 2017;11:153\u2013160. doi: 10.5897/JMPR2016.6266.", "ArticleIdList": ["10.5897/JMPR2016.6266"]}, {"Citation": "Kusindarta D.L., Wihadmadyatami H., Jadi A.R., Karnati S., Lochnit G., Hening P., Haryanto A., Auriva M.B., Purwaningrum M. Ethanolic extract Ocimum sanctum. Enhances cognitive ability from young adulthood to middle aged mediated by increasing choline acetyl transferase activity in rat model. Res. Vet. Sci. 2018;118:431\u2013438. doi: 10.1016/j.rvsc.2018.04.005.", "ArticleIdList": ["10.1016/j.rvsc.2018.04.005", "29729605"]}, {"Citation": "Antonescu Mintas A.I., Miere Groza F., Fritea L., Ganea M., Zdrinca M., Dobjanschi L., Antonescu A., Vicas S.I., Bodog F., Sindhu R.K., et al. Perspectives on the Combined Effects of Ocimum basilicum and Trifolium pratense Extracts in Terms of Phytochemical Profile and Pharmacological Effects. Plants. 2021;10:1390. doi: 10.3390/plants10071390.", "ArticleIdList": ["10.3390/plants10071390", "PMC8309466", "34371593"]}, {"Citation": "Ahuja A., Kim J.H., Kim J.H., Yi Y.S., Cho J.Y. Functional role of ginseng-derived compounds in cancer. J. Ginseng Res. 2018;42:248\u2013254. doi: 10.1016/j.jgr.2017.04.009.", "ArticleIdList": ["10.1016/j.jgr.2017.04.009", "PMC6026353", "29983605"]}, {"Citation": "Nieto G., Ros G., Castillo J. Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review. Medicines. 2018;5:98. doi: 10.3390/medicines5030098.", "ArticleIdList": ["10.3390/medicines5030098", "PMC6165352", "30181448"]}, {"Citation": "Lopresti A.L. Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects. Drugs R D. 2017;17:53\u201364. doi: 10.1007/s40268-016-0157-5.", "ArticleIdList": ["10.1007/s40268-016-0157-5", "PMC5318325", "27888449"]}, {"Citation": "Lee D.Y., Kim H.W., Yang H., Sung S.H. Hydrolyzable tannins from the fruits of Terminalia chebula Retz and their alpha-glucosidase inhibitory activities. Phytochemistry. 2017;137:109\u2013116. doi: 10.1016/j.phytochem.2017.02.006.", "ArticleIdList": ["10.1016/j.phytochem.2017.02.006", "28213992"]}, {"Citation": "Tiwari P., Nayak P., Prusty S.K., Sahu P.K. Phytochemistry and pharmacology of Tinospora cordifolia: A review. Syst. Rev. Pharm. 2018;9:70\u201378. doi: 10.5530/srp.2018.1.14.", "ArticleIdList": ["10.5530/srp.2018.1.14"]}, {"Citation": "RajaSankar S., Manivasagam T., Sankar V., Prakash S., Muthusamy R., Krishnamurti A., Surendran S. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J. Ethnopharmacol. 2009;125:369\u2013373. doi: 10.1016/j.jep.2009.08.003.", "ArticleIdList": ["10.1016/j.jep.2009.08.003", "19666100"]}, {"Citation": "Olasehinde T.A., Olaniran A.O., Okoh A.I. Therapeutic Potentials of Microalgae in the Treatment of Alzheimer\u2019s Disease. Molecules. 2017;22:480. doi: 10.3390/molecules22030480.", "ArticleIdList": ["10.3390/molecules22030480", "PMC6155420", "28335462"]}, {"Citation": "Stone N.L., Murphy A.J., England T.J., O\u2019Sullivan S.E. A systematic review of minor phytocannabinoids with promising neuroprotective potential. Br. J. Pharmacol. 2020;177:4330\u20134352. doi: 10.1111/bph.15185.", "ArticleIdList": ["10.1111/bph.15185", "PMC7484504", "32608035"]}, {"Citation": "Wyant K.J., Ridder A.J., Dayalu P. Huntington\u2019s Disease-Update on Treatments. Curr. Neurol. Neurosci. Rep. 2017;17:33. doi: 10.1007/s11910-017-0739-9.", "ArticleIdList": ["10.1007/s11910-017-0739-9", "28324302"]}, {"Citation": "Hussain G., Rasul A., Anwar H., Aziz N., Razzaq A., Wei W., Ali M., Li J., Li X. Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders. Int. J. Biol. Sci. 2018;14:341\u2013357. doi: 10.7150/ijbs.23247.", "ArticleIdList": ["10.7150/ijbs.23247", "PMC5859479", "29559851"]}, {"Citation": "Kumar A., Chaudhary R.K., Singh R., Singh S.P., Wang S.Y., Hoe Z.Y., Pan C.T., Shiue Y.L., Wei D.Q., Kaushik A.C., et al. Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases. Front. Neurosci. 2020;14:305. doi: 10.3389/fnins.2020.00305.", "ArticleIdList": ["10.3389/fnins.2020.00305", "PMC7203731", "32425743"]}, {"Citation": "Khalil A.T., Ovais M., Ullah I., Ali M., Shinwari Z.K., Khamlich S., Maaza M. Sageretia thea (Osbeck.) mediated synthesis of zinc oxide nanoparticles and its biological applications. Nanomedicine. 2017;12:1767\u20131789. doi: 10.2217/nnm-2017-0124.", "ArticleIdList": ["10.2217/nnm-2017-0124", "28699838"]}, {"Citation": "Ovais M., Zia N., Ahmad I., Khalil A.T., Raza A., Ayaz M., Sadiq A., Ullah F., Shinwari Z.K. Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer\u2019s Disease: Present Status and Future Opportunities. Front. Aging Neurosci. 2018;10:284. doi: 10.3389/fnagi.2018.00284.", "ArticleIdList": ["10.3389/fnagi.2018.00284", "PMC6205985", "30405389"]}, {"Citation": "Ovais M., Nadhman A., Khalil A.T., Raza A., Khuda F., Sohail M.F., Islam N.U., Sarwar H.S., Shahnaz G., Ahmad I., et al. Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: An insight. Nanomedicine. 2017;12:2807\u20132819. doi: 10.2217/nnm-2017-0233.", "ArticleIdList": ["10.2217/nnm-2017-0233", "29111869"]}, {"Citation": "Gaude T.T., Soares G.A.B.e., Priolkar R.N.S., Biradar B., Mamledesai S. Synthesis of 4-hydroxy-1-(phenyl/methyl)-3-[3-(substituted amino)-2-nitropropanoyl] quinolin-2(1H)-ones as an antimicrobial andantitubercular agents. Indian J. Heterocycl. Chem. 2017;27:223\u2013228."}, {"Citation": "Emmanuel R., Saravanan M., Ovais M., Padmavathy S., Shinwari Z.K., Prakash P. Antimicrobial efficacy of drug blended biosynthesized colloidal gold nanoparticles from Justicia glauca against oral pathogens: A nanoantibiotic approach. Microb. Pathog. 2017;113:295\u2013302. doi: 10.1016/j.micpath.2017.10.055.", "ArticleIdList": ["10.1016/j.micpath.2017.10.055", "29101061"]}, {"Citation": "Suganthy N., Sri Ramkumar V., Pugazhendhi A., Benelli G., Archunan G. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: Assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ. Sci. Pollut. Res. Int. 2018;25:10418\u201310433. doi: 10.1007/s11356-017-9789-4.", "ArticleIdList": ["10.1007/s11356-017-9789-4", "28762049"]}, {"Citation": "Reddy P.H., Manczak M., Yin X., Grady M.C., Mitchell A., Tonk S., Kuruva C.S., Bhatti J.S., Kandimalla R., Vijayan M., et al. Protective Effects of Indian Spice Curcumin against Amyloid-beta in Alzheimer\u2019s Disease. J. Alzheimers. Dis. 2018;61:843\u2013866. doi: 10.3233/JAD-170512.", "ArticleIdList": ["10.3233/JAD-170512", "PMC5796761", "29332042"]}, {"Citation": "Yusuf M., Khan M., Alrobaian M.M., Alghamdi S.A., Warsi M.H., Sultana S., Khan R.A. Brain targeted Polysorbate-80 coated PLGA thymoquinone nanoparticles for the treatment of Alzheimer\u2019s disease, with biomechanistic insights. J. Drug Deliv. Sci. Technol. 2021;61:102214. doi: 10.1016/j.jddst.2020.102214.", "ArticleIdList": ["10.1016/j.jddst.2020.102214"]}, {"Citation": "Xu R., Wang J., Xu J., Song X., Huang H., Feng Y., Fu C. Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer\u2019s Disease. Int. J. Nanomed. 2020;15:1149\u20131160. doi: 10.2147/IJN.S236922.", "ArticleIdList": ["10.2147/IJN.S236922", "PMC7035889", "32110013"]}, {"Citation": "Jacob J., Haponiuk J.T., Thomas S., Gopi S. Biopolymer based nanomaterials in drug delivery systems: A Review. Mater. Today Chem. 2018;9:43\u201355. doi: 10.1016/j.mtchem.2018.05.002.", "ArticleIdList": ["10.1016/j.mtchem.2018.05.002"]}, {"Citation": "Numata K., Kaplan D.L. Silk-based delivery systems of bioactive molecules. Adv. Drug Deliv. Rev. 2010;62:1497\u20131508. doi: 10.1016/j.addr.2010.03.009.", "ArticleIdList": ["10.1016/j.addr.2010.03.009", "PMC2901564", "20298729"]}, {"Citation": "Chopra H., Kumar S., Singh I. Biopolymer-based Scaffolds for Tissue Engineering Applications. Curr. Drug Targets. 2021;22:282\u2013295. doi: 10.2174/1389450121999201102140408.", "ArticleIdList": ["10.2174/1389450121999201102140408", "33143611"]}, {"Citation": "Langer K., Balthasar S., Vogel V., Dinauer N., Briesen H.v., Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 2003;257:169\u2013180. doi: 10.1016/S0378-5173(03)00134-0.", "ArticleIdList": ["10.1016/S0378-5173(03)00134-0", "12711172"]}, {"Citation": "Jahanban-Esfahlan A., Dastmalchi S., Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int. J. Biol. Macromol. 2016;91:703\u2013709. doi: 10.1016/j.ijbiomac.2016.05.032.", "ArticleIdList": ["10.1016/j.ijbiomac.2016.05.032", "27177461"]}, {"Citation": "Kratz F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Control. Release. 2008;132:171\u2013183. doi: 10.1016/j.jconrel.2008.05.010.", "ArticleIdList": ["10.1016/j.jconrel.2008.05.010", "18582981"]}, {"Citation": "Sathya S., Shanmuganathan B., Devi K.P. Deciphering the anti-apoptotic potential of alpha-bisabolol loaded solid lipid nanoparticles against Abeta induced neurotoxicity in Neuro-2a cells. Colloids Surf. B Biointerfaces. 2020;190:110948. doi: 10.1016/j.colsurfb.2020.110948.", "ArticleIdList": ["10.1016/j.colsurfb.2020.110948", "32160583"]}, {"Citation": "Pinheiro R.G.R., Granja A., Loureiro J.A., Pereira M.C., Pinheiro M., Neves A.R., Reis S. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer\u2019s disease. Eur. J. Pharm. Sci. 2020;148:105314. doi: 10.1016/j.ejps.2020.105314.", "ArticleIdList": ["10.1016/j.ejps.2020.105314", "32200044"]}, {"Citation": "Giacomeli R., Izoton J.C., Dos Santos R.B., Boeira S.P., Jesse C.R., Haas S.E. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer\u2019s disease induced by beta-amyloid 1-42 peptide in aged female mice. Brain Res. 2019;1721:146325. doi: 10.1016/j.brainres.2019.146325.", "ArticleIdList": ["10.1016/j.brainres.2019.146325", "31325424"]}, {"Citation": "Mathew A., Fukuda T., Nagaoka Y., Hasumura T., Morimoto H., Yoshida Y., Maekawa T., Venugopal K., Kumar D.S. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS ONE. 2012;7:e32616. doi: 10.1371/journal.pone.0032616.", "ArticleIdList": ["10.1371/journal.pone.0032616", "PMC3293842", "22403681"]}, {"Citation": "Pinheiro R.G.R., Granja A., Loureiro J.A., Pereira M.C., Pinheiro M., Neves A.R., Reis S. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer\u2019s Disease. Pharm. Res. 2020;37:139. doi: 10.1007/s11095-020-02865-1.", "ArticleIdList": ["10.1007/s11095-020-02865-1", "32661727"]}, {"Citation": "Cano A., Ettcheto M., Chang J.H., Barroso E., Espina M., Kuhne B.A., Barenys M., Auladell C., Folch J., Souto E.B., et al. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer\u2019s disease mice model. J. Control. Release. 2019;301:62\u201375. doi: 10.1016/j.jconrel.2019.03.010.", "ArticleIdList": ["10.1016/j.jconrel.2019.03.010", "PMC6510952", "30876953"]}, {"Citation": "Zhao Y., Xiong S., Liu P., Liu W., Wang Q., Liu Y., Tan H., Chen X., Shi X., Wang Q., et al. Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson\u2019s Disease. Int. J. Nanomed. 2020;15:10453\u201310467. doi: 10.2147/IJN.S272831.", "ArticleIdList": ["10.2147/IJN.S272831", "PMC7769078", "33380795"]}, {"Citation": "Xue Y., Wang N., Zeng Z., Huang J., Xiang Z., Guan Y.-Q. Neuroprotective effect of chitosan nanoparticle gene delivery system grafted with acteoside (ACT) in Parkinson\u2019s disease models. J. Mater. Sci. Technol. 2020;43:197\u2013207. doi: 10.1016/j.jmst.2019.10.013.", "ArticleIdList": ["10.1016/j.jmst.2019.10.013"]}, {"Citation": "Tan J.P.K., Voo Z.X., Lim S., Venkataraman S., Ng K.M., Gao S., Hedrick J.L., Yang Y.Y. Effective encapsulation of apomorphine into biodegradable polymeric nanoparticles through a reversible chemical bond for delivery across the blood-brain barrier. Nanomedicine. 2019;17:236\u2013245. doi: 10.1016/j.nano.2019.01.014.", "ArticleIdList": ["10.1016/j.nano.2019.01.014", "30738234"]}, {"Citation": "Chopra H., Kumar S., Singh I. Strategies and Therapies for Wound Healing: A Review. Curr. Drug Targets. 2021;23:87\u201398. doi: 10.2174/1389450122666210415101218.", "ArticleIdList": ["10.2174/1389450122666210415101218", "33858310"]}, {"Citation": "Li J., Han Y., Li M., Nie C. Curcumin Promotes Proliferation of Adult Neural Stem Cells and the Birth of Neurons in Alzheimer\u2019s Disease Mice via Notch Signaling Pathway. Cell. Reprogram. 2019;21:152\u2013161. doi: 10.1089/cell.2018.0027.", "ArticleIdList": ["10.1089/cell.2018.0027", "31145652"]}, {"Citation": "Joshi S., Singh-Moon R.P., Ellis J.A., Chaudhuri D.B., Wang M., Reif R., Bruce J.N., Bigio I.J., Straubinger R.M. Cerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing rats. Neurosurgery. 2015;76:92\u2013100. doi: 10.1227/NEU.0000000000000552.", "ArticleIdList": ["10.1227/NEU.0000000000000552", "PMC4273869", "25525695"]}, {"Citation": "Noble G.T., Stefanick J.F., Ashley J.D., Kiziltepe T., Bilgicer B. Ligand-targeted liposome design: Challenges and fundamental considerations. Trends Biotechnol. 2014;32:32\u201345. doi: 10.1016/j.tibtech.2013.09.007.", "ArticleIdList": ["10.1016/j.tibtech.2013.09.007", "24210498"]}, {"Citation": "Sancini G., Gregori M., Salvati E., Cambianica I., Re F., Ornaghi F., Canovi M., Fracasso C., Cagnotto A., Colombo M., et al. Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-\u03b2 peptide. J. Nanomed. Nanotechnol. 2013;4:171. doi: 10.4172/2157-7439.1000171.", "ArticleIdList": ["10.4172/2157-7439.1000171"]}, {"Citation": "Mourtas S., Lazar A.N., Markoutsa E., Duyckaerts C., Antimisiaris S.G. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur. J. Med. Chem. 2014;80:175\u2013183. doi: 10.1016/j.ejmech.2014.04.050.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.050", "24780594"]}, {"Citation": "Naik S.R., Pilgaonkar V.W., Panda V.S. Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain. Phytother. Res. 2006;20:1013\u20131016. doi: 10.1002/ptr.1976.", "ArticleIdList": ["10.1002/ptr.1976", "16909446"]}, {"Citation": "Uchegbu I.F., Vyas S.P. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 1998;172:33\u201370. doi: 10.1016/S0378-5173(98)00169-0.", "ArticleIdList": ["10.1016/S0378-5173(98)00169-0"]}, {"Citation": "Jin Y., Wen J., Garg S., Liu D., Zhou Y., Teng L., Zhang W. Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int J Nanomed. 2013;8:421\u2013430. doi: 10.2147/IJN.S37984.", "ArticleIdList": ["10.2147/IJN.S37984", "PMC3559077", "23378764"]}, {"Citation": "Poka L.P., Mohan G.K., Rao K.V., Shanker K. Neuroprotective Effect of Green Synthesized Iron Oxide Nanoparticles Using Aqueous Extract of Convolvulus Pluricaulis Plant in The Management of Alzheimer\u2019s Disease. Phytopathology. 2017;9:703\u2013709. doi: 10.25258/phyto.v9i5.8152.", "ArticleIdList": ["10.25258/phyto.v9i5.8152"]}, {"Citation": "Dehvari M., Ghahghaei A. The effect of green synthesis silver nanoparticles (AgNPs) from Pulicaria undulata on the amyloid formation in alpha-lactalbumin and the chaperon action of alpha-casein. Int. J. Biol. Macromol. 2018;108:1128\u20131139. doi: 10.1016/j.ijbiomac.2017.12.040.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.12.040", "29225181"]}, {"Citation": "Nagamune T. Biomolecular engineering for nanobio/bionanotechnology. Nano Converg. 2017;4:9. doi: 10.1186/s40580-017-0103-4.", "ArticleIdList": ["10.1186/s40580-017-0103-4", "PMC5401866", "28491487"]}, {"Citation": "Kaushik A. Biomedical Nanotechnology Related Grand Challenges and Perspectives. Front. Nanotechnol. 2019;1 doi: 10.3389/fnano.2019.00001.", "ArticleIdList": ["10.3389/fnano.2019.00001"]}, {"Citation": "Maojo V., Fritts M., Martin-Sanchez F., De la Iglesia D., Cachau R.E., Garcia-Remesal M., Crespo J., Mitchell J.A., Anguita A., Baker N., et al. Nanoinformatics: Developing new computing applications for nanomedicine. Comput. Sci. Eng. 2012;94:521\u2013539. doi: 10.1007/s00607-012-0191-2.", "ArticleIdList": ["10.1007/s00607-012-0191-2", "PMC3430140", "22942787"]}, {"Citation": "Heath J.R. Nanotechnologies for biomedical science and translational medicine. Proc. Natl. Acad. Sci. USA. 2015;112:14436\u201314443. doi: 10.1073/pnas.1515202112.", "ArticleIdList": ["10.1073/pnas.1515202112", "PMC4664315", "26598663"]}, {"Citation": "Zlokovic B.V. Current treatments and therapeutic targets in Alzheimer\u2019s disease. Adv. Drug Deliv. Rev. 2002;54:1533\u20131537. doi: 10.1016/S0169-409X(02)00150-3.", "ArticleIdList": ["10.1016/S0169-409X(02)00150-3", "12453670"]}, {"Citation": "Loera-Valencia R., Cedazo-Minguez A., Kenigsberg P.A., Page G., Duarte A.I., Giusti P., Zusso M., Robert P., Frisoni G.B., Cattaneo A., et al. Current and emerging avenues for Alzheimer\u2019s disease drug targets. J. Intern. Med. 2019;286:398\u2013437. doi: 10.1111/joim.12959.", "ArticleIdList": ["10.1111/joim.12959", "31286586"]}, {"Citation": "Cummings J., Lee G., Ritter A., Sabbagh M., Zhong K. Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement. 2020;6:e12050. doi: 10.1002/trc2.12050.", "ArticleIdList": ["10.1002/trc2.12050", "PMC7364858", "32695874"]}, {"Citation": "Huang L.K., Chao S.P., Hu C.J. Clinical trials of new drugs for Alzheimer disease. J. Biomed. Sci. 2020;27:18. doi: 10.1186/s12929-019-0609-7.", "ArticleIdList": ["10.1186/s12929-019-0609-7", "PMC6943903", "31906949"]}, {"Citation": "Fu L.M., Li J.T. A systematic review of single chinese herbs for Alzheimer\u2019s disease treatment. Evid. Based Complement. Altern. Med. 2011;2011:640284. doi: 10.1093/ecam/nep136.", "ArticleIdList": ["10.1093/ecam/nep136", "PMC3136754", "19737808"]}, {"Citation": "Banks W.A., Greig N.H. Small molecules as central nervous system therapeutics: Old challenges, new directions, and a philosophic divide. Future Med. Chem. 2019;11:489\u2013493. doi: 10.4155/fmc-2018-0436.", "ArticleIdList": ["10.4155/fmc-2018-0436", "30912980"]}, {"Citation": "Grabrucker A.M., Ruozi B., Belletti D., Pederzoli F., Forni F., Vandelli M.A., Tosi G. Nanoparticle transport across the blood brain barrier. Tissue Barriers. 2016;4:e1153568. doi: 10.1080/21688370.2016.1153568.", "ArticleIdList": ["10.1080/21688370.2016.1153568", "PMC4836460", "27141426"]}, {"Citation": "Mulvihill J.J., Cunnane E.M., Ross A.M., Duskey J.T., Tosi G., Grabrucker A.M. Drug delivery across the blood-brain barrier: Recent advances in the use of nanocarriers. Nanomedicine. 2020;15:205\u2013214. doi: 10.2217/nnm-2019-0367.", "ArticleIdList": ["10.2217/nnm-2019-0367", "31916480"]}, {"Citation": "Patra J.K., Das G., Fraceto L.F., Campos E.V.R., Rodriguez-Torres M.D.P., Acosta-Torres L.S., Diaz-Torres L.A., Grillo R., Swamy M.K., Sharma S., et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018;16:71. doi: 10.1186/s12951-018-0392-8.", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Ashish N., Bhatt P., Toga A.W. Global Data Sharing in Alzheimer Disease Research. Alzheimer. Dis. Assoc. Disord. 2016;30:160\u2013168. doi: 10.1097/WAD.0000000000000121.", "ArticleIdList": ["10.1097/WAD.0000000000000121", "PMC4851599", "26523713"]}, {"Citation": "Wang Z., Yang H., Wu Z., Wang T., Li W., Tang Y., Liu G. In Silico Prediction of Blood-Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods. ChemMedChem. 2018;13:2189\u20132201. doi: 10.1002/cmdc.201800533.", "ArticleIdList": ["10.1002/cmdc.201800533", "30110511"]}, {"Citation": "Belmadani M., Jacobson M., Holmes N., Phan M., Nguyen T., Pavlidis P., Rogic S. VariCarta: A Comprehensive Database of Harmonized Genomic Variants Found in Autism Spectrum Disorder Sequencing Studies. Autism. Res. 2019;12:1728\u20131736. doi: 10.1002/aur.2236.", "ArticleIdList": ["10.1002/aur.2236", "31705629"]}, {"Citation": "Shaker B., Yu M.S., Song J.S., Ahn S., Ryu J.Y., Oh K.S., Na D. LightBBB: Computational prediction model of blood-brain-barrier penetration based on LightGBM. Bioinformatics. 2021;37:1135\u20131139. doi: 10.1093/bioinformatics/btaa918.", "ArticleIdList": ["10.1093/bioinformatics/btaa918", "33112379"]}, {"Citation": "Wang C.N., Wang Y.J., Wang H., Song L., Chen Y., Wang J.L., Ye Y., Jiang B. The Anti-dementia Effects of Donepezil Involve miR-206-3p in the Hippocampus and Cortex. Biol. Pharm. Bull. 2017;40:465\u2013472. doi: 10.1248/bpb.b16-00898.", "ArticleIdList": ["10.1248/bpb.b16-00898", "28123152"]}, {"Citation": "Huang W., Li Z., Zhao L., Zhao W. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer\u2019s disease via modulating the expression of miR-106b. Biomed. Pharmacother. 2017;92:46\u201357. doi: 10.1016/j.biopha.2017.05.060.", "ArticleIdList": ["10.1016/j.biopha.2017.05.060", "28528185"]}, {"Citation": "Li S.H., Gao P., Wang L.T., Yan Y.H., Xia Y., Song J., Li H.Y., Yang J.X. Osthole Stimulated Neural Stem Cells Differentiation into Neurons in an Alzheimer\u2019s Disease Cell Model via Upregulation of MicroRNA-9 and Rescued the Functional Impairment of Hippocampal Neurons in APP/PS1 Transgenic Mice. Front. Neurosci. 2017;11:340. doi: 10.3389/fnins.2017.00340.", "ArticleIdList": ["10.3389/fnins.2017.00340", "PMC5468409", "28659755"]}, {"Citation": "Jang M., Choi S.H., Choi J.H., Oh J., Lee R.M., Lee N.E., Cho Y.J., Rhim H., Kim H.C., Cho I.H., et al. Ginseng gintonin attenuates the disruptions of brain microvascular permeability and microvascular endothelium junctional proteins in an APPswe/PSEN-1 double-transgenic mouse model of Alphalzheimer\u2019s disease. Exp. Ther. Med. 2021;21:310. doi: 10.3892/etm.2021.9741.", "ArticleIdList": ["10.3892/etm.2021.9741", "PMC7885069", "33717253"]}, {"Citation": "Shi R., Zhang S., Cheng G., Yang X., Zhao N., Chen C. Ginsenoside Rg1 and Acori Graminei Rhizoma Attenuates Neuron Cell Apoptosis by Promoting the Expression of miR-873-5p in Alzheimer\u2019s Disease. Neurochem. Res. 2018;43:1529\u20131538. doi: 10.1007/s11064-018-2567-y.", "ArticleIdList": ["10.1007/s11064-018-2567-y", "29926354"]}, {"Citation": "Caggiu E., Paulus K., Mameli G., Arru G., Sechi G.P., Sechi L.A. Differential expression of miRNA 155 and miRNA 146a in Parkinson\u2019s disease patients. Eneurologicalsci. 2018;13:1\u20134. doi: 10.1016/j.ensci.2018.09.002.", "ArticleIdList": ["10.1016/j.ensci.2018.09.002", "PMC6149197", "30255159"]}, {"Citation": "Serafin A., Foco L., Zanigni S., Blankenburg H., Picard A., Zanon A., Giannini G., Pichler I., Facheris M.F., Cortelli P., et al. Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. Neurology. 2015;84:645\u2013653. doi: 10.1212/WNL.0000000000001258.", "ArticleIdList": ["10.1212/WNL.0000000000001258", "25596505"]}, {"Citation": "Schwienbacher C., Foco L., Picard A., Corradi E., Serafin A., Panzer J., Zanigni S., Blankenburg H., Facheris M.F., Giannini G., et al. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson\u2019s Disease. J. Mol. Neurosci. 2017;62:244\u2013254. doi: 10.1007/s12031-017-0926-9.", "ArticleIdList": ["10.1007/s12031-017-0926-9", "28540642"]}, {"Citation": "Alieva A., Filatova E.V., Karabanov A.V., Illarioshkin S.N., Limborska S.A., Shadrina M.I., Slominsky P.A. miRNA expression is highly sensitive to a drug therapy in Parkinson\u2019s disease. Parkinsonism. Relat. Disord. 2015;21:72\u201374. doi: 10.1016/j.parkreldis.2014.10.018.", "ArticleIdList": ["10.1016/j.parkreldis.2014.10.018", "25465742"]}, {"Citation": "Waschbisch A., Atiya M., Linker R.A., Potapov S., Schwab S., Derfuss T. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS ONE. 2011;6:e24604. doi: 10.1371/journal.pone.0024604.", "ArticleIdList": ["10.1371/journal.pone.0024604", "PMC3174971", "21949733"]}, {"Citation": "Singh J., Deshpande M., Suhail H., Rattan R., Giri S. Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response. J. Neuroimmune Pharmacol. 2016;11:84\u201397. doi: 10.1007/s11481-015-9630-0.", "ArticleIdList": ["10.1007/s11481-015-9630-0", "26277791"]}, {"Citation": "Bergman P., Piket E., Khademi M., James T., Brundin L., Olsson T., Piehl F., Jagodic M. Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e219. doi: 10.1212/NXI.0000000000000219.", "ArticleIdList": ["10.1212/NXI.0000000000000219", "PMC4841644", "27144214"]}, {"Citation": "Fattahi M., Rezaei N., Nematalahi F.S., Shaygannejad V., Fouladi S., Karimi L., Fathi F., Dehghani L., Mirmosayyeb O., Eskandari N. MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis. Mult. Scler. Relat. Disord. 2019;35:241\u2013245. doi: 10.1016/j.msard.2019.07.034.", "ArticleIdList": ["10.1016/j.msard.2019.07.034", "31421628"]}, {"Citation": "Meira M., Sievers C., Hoffmann F., Derfuss T., Kuhle J., Kappos L., Lindberg R.L. MiR-126: A novel route for natalizumab action? Mult. Scler. 2014;20:1363\u20131370. doi: 10.1177/1352458514524998.", "ArticleIdList": ["10.1177/1352458514524998", "24598267"]}, {"Citation": "Sievers C., Meira M., Hoffmann F., Fontoura P., Kappos L., Lindberg R.L. Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects. Clin. Immunol. 2012;144:70\u201379. doi: 10.1016/j.clim.2012.04.002.", "ArticleIdList": ["10.1016/j.clim.2012.04.002", "22659298"]}, {"Citation": "Ingwersen J., Menge T., Wingerath B., Kaya D., Graf J., Prozorovski T., Keller A., Backes C., Beier M., Scheffler M., et al. Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b. Ann. Clin. Transl. Neurol. 2015;2:43\u201355. doi: 10.1002/acn3.152.", "ArticleIdList": ["10.1002/acn3.152", "PMC4301674", "25642434"]}, {"Citation": "Michell-Robinson M.A., Moore C.S., Healy L.M., Osso L.A., Zorko N., Grouza V., Touil H., Poliquin-Lasnier L., Trudelle A.M., Giacomini P.S., et al. Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis. Ann. Clin. Transl. Neurol. 2016;3:27\u201341. doi: 10.1002/acn3.270.", "ArticleIdList": ["10.1002/acn3.270", "PMC4704479", "26783548"]}, {"Citation": "Eftekharian M.M., Komaki A., Mazdeh M., Arsang-Jang S., Taheri M., Ghafouri-Fard S. Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: A Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod. J. Mol. Neurosci. 2019;68:153\u2013161. doi: 10.1007/s12031-019-01294-z.", "ArticleIdList": ["10.1007/s12031-019-01294-z", "30895441"]}, {"Citation": "Vaknin-Dembinsky A., Charbit H., Brill L., Abramsky O., Gur-Wahnon D., Ben-Dov I.Z., Lavon I. Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) J. Neuroinflamm. 2016;13:179. doi: 10.1186/s12974-016-0648-x.", "ArticleIdList": ["10.1186/s12974-016-0648-x", "PMC4939003", "27393339"]}, {"Citation": "Ebrahimkhani S., Beadnall H.N., Wang C., Suter C.M., Barnett M.H., Buckland M.E., Vafaee F. Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment. Mol. Neurobiol. 2020;57:1245\u20131258. doi: 10.1007/s12035-019-01792-6.", "ArticleIdList": ["10.1007/s12035-019-01792-6", "31721043"]}, {"Citation": "Fattahi M., Eskandari N., Sotoodehnejadnematalahi F., Shaygannejad V., Kazemi M. Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis. Cell J. 2020;22:92\u201395. doi: 10.22074/cellj.2020.6486.", "ArticleIdList": ["10.22074/cellj.2020.6486", "PMC6791062", "31606972"]}, {"Citation": "De Felice B., Mondola P., Sasso A., Orefice G., Bresciamorra V., Vacca G., Biffali E., Borra M., Pannone R. Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta. BMC Med. Genom. 2014;7:26. doi: 10.1186/1755-8794-7-26.", "ArticleIdList": ["10.1186/1755-8794-7-26", "PMC4060096", "24885345"]}, {"Citation": "Munoz-Culla M., Irizar H., Castillo-Trivino T., Saenz-Cuesta M., Sepulveda L., Lopetegi I., Lopez de Munain A., Olascoaga J., Baranzini S.E., Otaegui D. Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients. Mult. Scler. 2014;20:1851\u20131859. doi: 10.1177/1352458514534513.", "ArticleIdList": ["10.1177/1352458514534513", "24852919"]}, {"Citation": "Fenoglio C., De Riz M., Pietroboni A.M., Calvi A., Serpente M., Cioffi S.M., Arcaro M., Oldoni E., Scarpini E., Galimberti D. Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis. J. Neuroimmunol. 2016;299:81\u201383. doi: 10.1016/j.jneuroim.2016.08.017.", "ArticleIdList": ["10.1016/j.jneuroim.2016.08.017", "27725128"]}, {"Citation": "Indrasekara A.S.D.S., Wadams R.C., Fabris L. Ligand Exchange on Gold Nanorods: Going Back to the Future. Part. Parcle Syst. Charact. 2014;31:819\u2013838. doi: 10.1002/ppsc.201400006.", "ArticleIdList": ["10.1002/ppsc.201400006"]}, {"Citation": "de Lau L.M., Koudstaal P.J., Witteman J.C., Hofman A., Breteler M.M. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology. 2006;67:315\u2013318. doi: 10.1212/01.wnl.0000225050.57553.6d.", "ArticleIdList": ["10.1212/01.wnl.0000225050.57553.6d", "16864826"]}, {"Citation": "Kim J.W., Galanzha E.I., Zaharoff D.A., Griffin R.J., Zharov V.P. Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo. Mol. Pharm. 2013;10:813\u2013830. doi: 10.1021/mp300577s.", "ArticleIdList": ["10.1021/mp300577s", "PMC3752784", "23379366"]}, {"Citation": "Rahman M., Akhter S., Ahmad M.Z., Ahmad J., Addo R.T., Ahmad F.J., Pichon C. Emerging advances in cancer nanotheranostics with graphene nanocomposites: Opportunities and challenges. Nanomedicine. 2015;10:2405\u20132422. doi: 10.2217/nnm.15.68.", "ArticleIdList": ["10.2217/nnm.15.68", "26252175"]}, {"Citation": "Li W., Luo R., Lin X., Jadhav A.D., Zhang Z., Yan L., Chan C.Y., Chen X., He J., Chen C.H., et al. Remote modulation of neural activities via near-infrared triggered release of biomolecules. Biomaterials. 2015;65:76\u201385. doi: 10.1016/j.biomaterials.2015.06.041.", "ArticleIdList": ["10.1016/j.biomaterials.2015.06.041", "26142778"]}, {"Citation": "Xue Y., Wu J., Sun J. Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. Toxicol. Lett. 2012;214:91\u201398. doi: 10.1016/j.toxlet.2012.08.009.", "ArticleIdList": ["10.1016/j.toxlet.2012.08.009", "22939914"]}, {"Citation": "Sunderland K.S., Yang M., Mao C. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine. Angew. Chem. Int. Ed. 2017;56:1964\u20131992. doi: 10.1002/anie.201606181.", "ArticleIdList": ["10.1002/anie.201606181", "PMC5311110", "27491926"]}, {"Citation": "Soliman H.M., Ghonaim G.A., Gharib S.M., Chopra H., Farag A.K., Hassanin M.H., Nagah A., Emad-Eldin M., Hashem N.E., Yahya G., et al. Exosomes in Alzheimer\u2019s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics. Int. J. Mol. Sci. 2021;22:794. doi: 10.3390/ijms221910794.", "ArticleIdList": ["10.3390/ijms221910794", "PMC8509246", "34639135"]}, {"Citation": "Tran P.H.L., Xiang D., Tran T.T.D., Yin W., Zhang Y., Kong L., Chen K., Sun M., Li Y., Hou Y., et al. Exosomes and Nanoengineering: A Match Made for Precision Therapeutics. Adv. Mater. 2020;32:e1904040. doi: 10.1002/adma.201904040.", "ArticleIdList": ["10.1002/adma.201904040", "31531916"]}, {"Citation": "Cavalu S., Ratiu C., Ponta O., Simon V., Rugina D., Miclaus V., Akin I., Goller G. Improving osseointegration of alumina/zirconia ceramic implants by fluoride surface treatment. Dig. J. Nanomater. Bios. 2014;9:797\u2013808."}, {"Citation": "Kandell R.M., Waggoner L.E., Kwon E.J. Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine. Mol. Pharm. 2021;18:522\u2013538. doi: 10.1021/acs.molpharmaceut.0c00287.", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c00287", "PMC7759589", "32584042"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "18"}, {"Year": "2022", "Month": "1", "Day": "16"}, {"Year": "2022", "Month": "1", "Day": "18"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "1", "Minute": "9"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35160749", "PMC8837051", "10.3390/ma15030804", "ma15030804"]}}], "PubmedBookArticle": []}